ArticleClinical interventions in aging2026
Development and Validation of a Machine Learning Model for Predicting Serum Creatinine-Defined Acute Kidney Injury in Older Adults After Cardiac Surgery.
Article in Clinical interventions in aging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiac surgery-associated acute kidney injury (CSA-AKI) is a frequent and devastating postoperative complication, particularly among older adults. Accurate risk stratification and early prediction of CSA-AKI are essential for guiding preventive strategies and optimizing clinical decision-making. Methods: In this retrospective study, data from two centers (n=623) were utilized for model training and internal validation, whereas data from a third, distinct center (n=110) were reserved for external validation. CSA-AKI was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) Serum creatinine criteria. Key predictors were identified using a consensus of four methods: Least Absolute Shrinkage and Selection Operator (LASSO), Recursive Feature Elimination (RFE), Boruta, and Random Forest-based filtering. Six machine learning (ML) models, including Logistic Regression (LR), K-Nearest Neighbors (KNN), Support Vector Machine (SVM), Random Forest (RF), Extreme Gradient Boosting (XGBoost), and Light Gradient Boosting Machine (LightGBM), were developed utilizing five-fold cross-validation. Predictive performance was assessed using the area under the receiver operating characteristic curve (AUC). The SHapley Additive exPlanations (SHAP) approach was applied to interpret the best-performing model. Results: Development of CSA-AKI was noted in 177 patients (24.1%) during the first postoperative week. In terms of comparative performance, LightGBM exhibited the greatest AUC (0.784, 95% confidence interval [CI]: 0.702-0.859). The most influential features were lactate, surgical duration, activated partial thromboplastin time (APTT), transfusion volume, and Prothrombin Time (PT). SHAP-based summary and force plots interpreted the model at global and local levels. Furthermore, SHAP dependence plots elucidated non-linear effects of single features on CSA-AKI risk. Conclusion: Machine learning models demonstrate high efficacy in predicting CSA-AKI risk in older adults. The LightGBM model outperformed other algorithms; coupled with interpretability tools, it can assist clinicians to identify high-risk patients earlier and optimize perioperative management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.